<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04959318</url>
  </required_header>
  <id_info>
    <org_study_id>219081</org_study_id>
    <nct_id>NCT04959318</nct_id>
  </id_info>
  <brief_title>Precision Nutrition Impact on Health-Related Behavior Change</brief_title>
  <official_title>Precision Nutrition Impact on Health-Related Behavior Change in Active Duty Service Members</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Madigan Army Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>TriService Nursing Research Program</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Madigan Army Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, randomized, controlled trial enrolling up to 150 service members (SMs) from&#xD;
      two sites; Joint Base Lewis McChord (JBLM) in the Northwest and Joint Base San Antonio&#xD;
      (JBSA)-Lackland in the Southwest. A baseline genomic profile (70 genes/80 single nucleotide&#xD;
      polymorphisms [SNPs]) augmented by common serum biomarkers specific to diet-related chronic&#xD;
      disease (metabolic syndrome, cardiovascular disease [CVD], vitamin D deficiency) risk will be&#xD;
      created. Subjects will be randomized to either personalized nutrition counseling or standard&#xD;
      nutrition education for 6 weeks. This interval matches Service-run healthy weight initiatives&#xD;
      such as the Army's current Fit for Performance Program. To promote self-care and engagement,&#xD;
      a digital app will be utilized for 2 weeks for real-time health data capture with continuous&#xD;
      feedback and will be validated with in-person RD interviews. Physical activity and injury&#xD;
      data, sun exposure, and family history will help elucidate unique individual responses.&#xD;
      Participant follow-up at 12 weeks will evaluate changes in anthropometrics and metabolic,&#xD;
      cardiovascular, and vitamin D biomarkers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Precision nutrition leverages the specificity of molecular and phenotypic differences in&#xD;
      personalizing diet and lifestyle interventions. Specific Aims: 1) Examine the effectiveness&#xD;
      of gene-based nutrition counseling on health-related behavior change in service members as&#xD;
      measured by body weight, body mass index (BMI), blood glucose, lipids, 25-hydroxyvitamin (OH)&#xD;
      D, %body fat (BF), waist circumference, and blood pressure; 2) Evaluate the feasibility of a&#xD;
      digital application to accurately capture diet, activity, and sleep behaviors; and 3)&#xD;
      Describe military-unique characteristics in demographics, diet, and lifestyle for northwest&#xD;
      Army and southwest Air Force cohorts.&#xD;
&#xD;
      A baseline genomic profile will be created from 70 diet-responsive genes and 80 variants&#xD;
      following amplicon sequencing on an Illumina MiSeq platform and will be informed by serum&#xD;
      biomarkers specific to diet-related chronic disease risk (i.e. metabolic syndrome, vitamin D&#xD;
      deficiency) for each subject. Risk variants were selected if minor allele frequency &gt; 5% and&#xD;
      at least two published papers verified the link to the phenotype of interest. Treatment group&#xD;
      receives gene-based nutrition counseling for six weekly sessions; Controls receive&#xD;
      evidence-based nutrition pamphlets, all content directed at preventing metabolic syndrome. A&#xD;
      digital app provides real-time health data capture with continuous feedback and is verified&#xD;
      by in-person dietitian interviews. Both groups will also use study resources independently&#xD;
      for six weeks, returning for final body composition and serum biomarkers after the&#xD;
      twelve-week intervention. The control group receives the genomic profile with dietary&#xD;
      recommendations upon study completion. Data analysis will examine between-group and by-cohort&#xD;
      differences on primary anthropometric and biomarker outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 20, 2019</start_date>
  <completion_date type="Anticipated">December 9, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 9, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Subjects were enrolled, submitted fasting blood sample, and returned for initial measurements when lab results were available. At this visit, randomization based on a random number generator and concealed allocation with sequentially numbered opaque envelopes took place. This allowed the first treatment/professional counseling session to be held the same day depending on group assignment.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The statistician is external to the research team and has not been involved throughout the trial period. She will receive data upon completion of the trial and perform the outcomes assessment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Weight loss</measure>
    <time_frame>12-14 weeks</time_frame>
    <description>Pounds lost between measurements</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body fat</measure>
    <time_frame>12-14 weeks</time_frame>
    <description>Percent change in body fat over time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>12-14 weeks</time_frame>
    <description>Change in waist circumference measured in inches to reduce risk for MetS over time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Cholesterol</measure>
    <time_frame>12-14 weeks</time_frame>
    <description>Blood level of serum cholesterol to reduce risk for MetS over time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic blood pressure</measure>
    <time_frame>12-14 weeks</time_frame>
    <description>Change in systolic blood pressure to reduce risk for MetS over time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic blood pressure</measure>
    <time_frame>12-14 weeks</time_frame>
    <description>Change in diastolic blood pressure to reduce risk for MetS over time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum glucose</measure>
    <time_frame>12-14 weeks</time_frame>
    <description>Change in blood glucose level to reduce risk for MetS over time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum triglyceride</measure>
    <time_frame>12 -14 weeks</time_frame>
    <description>Change in blood triglyceride level to reduce risk for MetS over time</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Treatment group or counseling group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The treatment group will receive a counseling intervention addressing metabolic syndrome (comprised of abdominal adiposity, high blood pressure, high cholesterol, elevated fasting glucose, and elevated triglyceride level) and low vitamin D. This group will undergo baseline body composition measurements, phlebotomy, and an introduction to the digital app for recording diet and activity.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group or comparison group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects randomized to the control group will undergo baseline body composition measurements, phlebotomy, and an introduction to the app for recording diet and activity. They will receive a packet of evidence-based pamphlets addressing Service-specific approaches to healthy eating and physical activity (e.g. Performance Triad). There will be no formal recurring interaction with an RD for those randomized to this control group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Professional nutrition counseling</intervention_name>
    <description>Published multi-cohort genome-wide association studies provided genes and genetic variants that are credibly associated with aspects of metabolic syndrome (MetS), CVD, overweight/obesity, and vitamin D metabolism. Registered dietitian (RD) counseling will review potentially harmful and protective variants for risk of MetS with subjects and make evidence-based recommendations to improve diet quality and achieve weight loss goals. Each of the 6 weekly sessions covered a specific component of MetS. Counseling will take place once a week either in-person or via phone/virtual platform based on preference and availability of the subject. Counselors will review digital app data entries for food intake prior to this interaction for the first 2 weeks.</description>
    <arm_group_label>Treatment group or counseling group</arm_group_label>
    <other_name>Gene-based dietary counseling</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No professional nutrition counseling</intervention_name>
    <description>Participants receive pamphlets with evidence-based general health, healthy nutrition, exercise and sleep content. They receive information on genetic variants related to MetS at end of study period.</description>
    <arm_group_label>Control group or comparison group</arm_group_label>
    <other_name>Pamphlets</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Active duty Army or Air Force&#xD;
&#xD;
          -  Age 18-45&#xD;
&#xD;
          -  Able to read and comprehend English&#xD;
&#xD;
          -  Assigned to JBLM or JBSA-Lackland,&#xD;
&#xD;
          -  Remaining on station for 5 months&#xD;
&#xD;
          -  Consider self generally healthy&#xD;
&#xD;
          -  History of or currently out of compliance with military fitness standards&#xD;
&#xD;
          -  Willing to submit 2 blood samples including one for gene testing&#xD;
&#xD;
          -  Willing to undergo 1 DEXA scan (JBLM only)&#xD;
&#xD;
          -  Willing to participate in 6 weekly nutrition counseling sessions if assigned to&#xD;
             treatment group&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Currently diagnosed with an eating disorder&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  Current physical training profile (ie limitation)&#xD;
&#xD;
          -  Pending deployment in next 5 months&#xD;
&#xD;
          -  Pending retirement in next 5 months&#xD;
&#xD;
          -  Pending permanent change of duty station in the next 5 months&#xD;
&#xD;
          -  Currently has a pacemaker (contraindicated for bioelectrical impedance analysis)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mary S McCarthy, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Madigan AMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Madigan Army Medical Center</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98431</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bray MS, Loos RJ, McCaffery JM, Ling C, Franks PW, Weinstock GM, Snyder MP, Vassy JL, Agurs-Collins T; Conference Working Group. NIH working group report-using genomic information to guide weight management: From universal to precision treatment. Obesity (Silver Spring). 2016 Jan;24(1):14-22. doi: 10.1002/oby.21381. Review. Erratum in: Obesity (Silver Spring). 2016 Mar;24(3):757.</citation>
    <PMID>26692578</PMID>
  </reference>
  <reference>
    <citation>de Toro-Martín J, Arsenault BJ, Després JP, Vohl MC. Precision Nutrition: A Review of Personalized Nutritional Approaches for the Prevention and Management of Metabolic Syndrome. Nutrients. 2017 Aug 22;9(8). pii: E913. doi: 10.3390/nu9080913. Review.</citation>
    <PMID>28829397</PMID>
  </reference>
  <reference>
    <citation>Povel CM, Boer JM, Onland-Moret NC, Dollé ME, Feskens EJ, van der Schouw YT. Single nucleotide polymorphisms (SNPs) involved in insulin resistance, weight regulation, lipid metabolism and inflammation in relation to metabolic syndrome: an epidemiological study. Cardiovasc Diabetol. 2012 Oct 29;11:133. doi: 10.1186/1475-2840-11-133.</citation>
    <PMID>23101478</PMID>
  </reference>
  <reference>
    <citation>Corella D, Coltell O, Mattingley G, Sorlí JV, Ordovas JM. Utilizing nutritional genomics to tailor diets for the prevention of cardiovascular disease: a guide for upcoming studies and implementations. Expert Rev Mol Diagn. 2017 May;17(5):495-513. doi: 10.1080/14737159.2017.1311208. Epub 2017 Apr 3. Review.</citation>
    <PMID>28337931</PMID>
  </reference>
  <reference>
    <citation>Celis-Morales C, Livingstone KM, Marsaux CF, Forster H, O'Donovan CB, Woolhead C, Macready AL, Fallaize R, Navas-Carretero S, San-Cristobal R, Kolossa S, Hartwig K, Tsirigoti L, Lambrinou CP, Moschonis G, Godlewska M, Surwiłło A, Grimaldi K, Bouwman J, Daly EJ, Akujobi V, O'Riordan R, Hoonhout J, Claassen A, Hoeller U, Gundersen TE, Kaland SE, Matthews JN, Manios Y, Traczyk I, Drevon CA, Gibney ER, Brennan L, Walsh MC, Lovegrove JA, Alfredo Martinez J, Saris WH, Daniel H, Gibney M, Mathers JC. Design and baseline characteristics of the Food4Me study: a web-based randomised controlled trial of personalised nutrition in seven European countries. Genes Nutr. 2015 Jan;10(1):450. doi: 10.1007/s12263-014-0450-2. Epub 2014 Dec 10.</citation>
    <PMID>25491748</PMID>
  </reference>
  <results_reference>
    <citation>Liang Y, Kelemen A. Shared polymorphisms and modifiable behavior factors for myocardial infarction and high cholesterol in a retrospective population study. Medicine (Baltimore). 2017 Sep;96(37):e7683. doi: 10.1097/MD.0000000000007683.</citation>
    <PMID>28906356</PMID>
  </results_reference>
  <results_reference>
    <citation>Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, Powell C, Vedantam S, Buchkovich ML, Yang J, Croteau-Chonka DC, Esko T, Fall T, Ferreira T, Gustafsson S, Kutalik Z, Luan J, Mägi R, Randall JC, Winkler TW, Wood AR, Workalemahu T, Faul JD, Smith JA, Zhao JH, Zhao W, Chen J, Fehrmann R, Hedman ÅK, Karjalainen J, Schmidt EM, Absher D, Amin N, Anderson D, Beekman M, Bolton JL, Bragg-Gresham JL, Buyske S, Demirkan A, Deng G, Ehret GB, Feenstra B, Feitosa MF, Fischer K, Goel A, Gong J, Jackson AU, Kanoni S, Kleber ME, Kristiansson K, Lim U, Lotay V, Mangino M, Leach IM, Medina-Gomez C, Medland SE, Nalls MA, Palmer CD, Pasko D, Pechlivanis S, Peters MJ, Prokopenko I, Shungin D, Stančáková A, Strawbridge RJ, Sung YJ, Tanaka T, Teumer A, Trompet S, van der Laan SW, van Setten J, Van Vliet-Ostaptchouk JV, Wang Z, Yengo L, Zhang W, Isaacs A, Albrecht E, Ärnlöv J, Arscott GM, Attwood AP, Bandinelli S, Barrett A, Bas IN, Bellis C, Bennett AJ, Berne C, Blagieva R, Blüher M, Böhringer S, Bonnycastle LL, Böttcher Y, Boyd HA, Bruinenberg M, Caspersen IH, Chen YI, Clarke R, Daw EW, de Craen AJM, Delgado G, Dimitriou M, Doney ASF, Eklund N, Estrada K, Eury E, Folkersen L, Fraser RM, Garcia ME, Geller F, Giedraitis V, Gigante B, Go AS, Golay A, Goodall AH, Gordon SD, Gorski M, Grabe HJ, Grallert H, Grammer TB, Gräßler J, Grönberg H, Groves CJ, Gusto G, Haessler J, Hall P, Haller T, Hallmans G, Hartman CA, Hassinen M, Hayward C, Heard-Costa NL, Helmer Q, Hengstenberg C, Holmen O, Hottenga JJ, James AL, Jeff JM, Johansson Å, Jolley J, Juliusdottir T, Kinnunen L, Koenig W, Koskenvuo M, Kratzer W, Laitinen J, Lamina C, Leander K, Lee NR, Lichtner P, Lind L, Lindström J, Lo KS, Lobbens S, Lorbeer R, Lu Y, Mach F, Magnusson PKE, Mahajan A, McArdle WL, McLachlan S, Menni C, Merger S, Mihailov E, Milani L, Moayyeri A, Monda KL, Morken MA, Mulas A, Müller G, Müller-Nurasyid M, Musk AW, Nagaraja R, Nöthen MM, Nolte IM, Pilz S, Rayner NW, Renstrom F, Rettig R, Ried JS, Ripke S, Robertson NR, Rose LM, Sanna S, Scharnagl H, Scholtens S, Schumacher FR, Scott WR, Seufferlein T, Shi J, Smith AV, Smolonska J, Stanton AV, Steinthorsdottir V, Stirrups K, Stringham HM, Sundström J, Swertz MA, Swift AJ, Syvänen AC, Tan ST, Tayo BO, Thorand B, Thorleifsson G, Tyrer JP, Uh HW, Vandenput L, Verhulst FC, Vermeulen SH, Verweij N, Vonk JM, Waite LL, Warren HR, Waterworth D, Weedon MN, Wilkens LR, Willenborg C, Wilsgaard T, Wojczynski MK, Wong A, Wright AF, Zhang Q; LifeLines Cohort Study, Brennan EP, Choi M, Dastani Z, Drong AW, Eriksson P, Franco-Cereceda A, Gådin JR, Gharavi AG, Goddard ME, Handsaker RE, Huang J, Karpe F, Kathiresan S, Keildson S, Kiryluk K, Kubo M, Lee JY, Liang L, Lifton RP, Ma B, McCarroll SA, McKnight AJ, Min JL, Moffatt MF, Montgomery GW, Murabito JM, Nicholson G, Nyholt DR, Okada Y, Perry JRB, Dorajoo R, Reinmaa E, Salem RM, Sandholm N, Scott RA, Stolk L, Takahashi A, Tanaka T, van 't Hooft FM, Vinkhuyzen AAE, Westra HJ, Zheng W, Zondervan KT; ADIPOGen Consortium; AGEN-BMI Working Group; CARDIOGRAMplusC4D Consortium; CKDGen Consortium; GLGC; ICBP; MAGIC Investigators; MuTHER Consortium; MIGen Consortium; PAGE Consortium; ReproGen Consortium; GENIE Consortium; International Endogene Consortium, Heath AC, Arveiler D, Bakker SJL, Beilby J, Bergman RN, Blangero J, Bovet P, Campbell H, Caulfield MJ, Cesana G, Chakravarti A, Chasman DI, Chines PS, Collins FS, Crawford DC, Cupples LA, Cusi D, Danesh J, de Faire U, den Ruijter HM, Dominiczak AF, Erbel R, Erdmann J, Eriksson JG, Farrall M, Felix SB, Ferrannini E, Ferrières J, Ford I, Forouhi NG, Forrester T, Franco OH, Gansevoort RT, Gejman PV, Gieger C, Gottesman O, Gudnason V, Gyllensten U, Hall AS, Harris TB, Hattersley AT, Hicks AA, Hindorff LA, Hingorani AD, Hofman A, Homuth G, Hovingh GK, Humphries SE, Hunt SC, Hyppönen E, Illig T, Jacobs KB, Jarvelin MR, Jöckel KH, Johansen B, Jousilahti P, Jukema JW, Jula AM, Kaprio J, Kastelein JJP, Keinanen-Kiukaanniemi SM, Kiemeney LA, Knekt P, Kooner JS, Kooperberg C, Kovacs P, Kraja AT, Kumari M, Kuusisto J, Lakka TA, Langenberg C, Marchand LL, Lehtimäki T, Lyssenko V, Männistö S, Marette A, Matise TC, McKenzie CA, McKnight B, Moll FL, Morris AD, Morris AP, Murray JC, Nelis M, Ohlsson C, Oldehinkel AJ, Ong KK, Madden PAF, Pasterkamp G, Peden JF, Peters A, Postma DS, Pramstaller PP, Price JF, Qi L, Raitakari OT, Rankinen T, Rao DC, Rice TK, Ridker PM, Rioux JD, Ritchie MD, Rudan I, Salomaa V, Samani NJ, Saramies J, Sarzynski MA, Schunkert H, Schwarz PEH, Sever P, Shuldiner AR, Sinisalo J, Stolk RP, Strauch K, Tönjes A, Trégouët DA, Tremblay A, Tremoli E, Virtamo J, Vohl MC, Völker U, Waeber G, Willemsen G, Witteman JC, Zillikens MC, Adair LS, Amouyel P, Asselbergs FW, Assimes TL, Bochud M, Boehm BO, Boerwinkle E, Bornstein SR, Bottinger EP, Bouchard C, Cauchi S, Chambers JC, Chanock SJ, Cooper RS, de Bakker PIW, Dedoussis G, Ferrucci L, Franks PW, Froguel P, Groop LC, Haiman CA, Hamsten A, Hui J, Hunter DJ, Hveem K, Kaplan RC, Kivimaki M, Kuh D, Laakso M, Liu Y, Martin NG, März W, Melbye M, Metspalu A, Moebus S, Munroe PB, Njølstad I, Oostra BA, Palmer CNA, Pedersen NL, Perola M, Pérusse L, Peters U, Power C, Quertermous T, Rauramaa R, Rivadeneira F, Saaristo TE, Saleheen D, Sattar N, Schadt EE, Schlessinger D, Slagboom PE, Snieder H, Spector TD, Thorsteinsdottir U, Stumvoll M, Tuomilehto J, Uitterlinden AG, Uusitupa M, van der Harst P, Walker M, Wallaschofski H, Wareham NJ, Watkins H, Weir DR, Wichmann HE, Wilson JF, Zanen P, Borecki IB, Deloukas P, Fox CS, Heid IM, O'Connell JR, Strachan DP, Stefansson K, van Duijn CM, Abecasis GR, Franke L, Frayling TM, McCarthy MI, Visscher PM, Scherag A, Willer CJ, Boehnke M, Mohlke KL, Lindgren CM, Beckmann JS, Barroso I, North KE, Ingelsson E, Hirschhorn JN, Loos RJF, Speliotes EK. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015 Feb 12;518(7538):197-206. doi: 10.1038/nature14177.</citation>
    <PMID>25673413</PMID>
  </results_reference>
  <results_reference>
    <citation>Joseph MS, Konerman MA, Zhang M, Wei B, Brinza E, Walden P, Jackson EA, Rubenfire M. Long-term outcomes following completion of a structured nutrition and exercise lifestyle intervention program for patients with metabolic syndrome. Diabetes Metab Syndr Obes. 2018 Nov 15;11:753-759. doi: 10.2147/DMSO.S175858. eCollection 2018.</citation>
    <PMID>30532575</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 1, 2021</study_first_submitted>
  <study_first_submitted_qc>July 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 13, 2021</study_first_posted>
  <last_update_submitted>September 30, 2021</last_update_submitted>
  <last_update_submitted_qc>September 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Madigan Army Medical Center</investigator_affiliation>
    <investigator_full_name>Mary McCarthy</investigator_full_name>
    <investigator_title>Nurse Scientist</investigator_title>
  </responsible_party>
  <keyword>nutrition</keyword>
  <keyword>military</keyword>
  <keyword>nutrigenomics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

